Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
The "Three Products" strategy shows results; Health Yuan's star product wins another award
Published Time：
2019-03-27
On March 15th, the "Guangdong Pharmaceutical Industry Implementation of the Three-Product Strategy Achievements Release Conference and Association Annual Meeting" was held in Guangzhou. Vice Director Yan Zhen of the Guangdong Drug Administration and other relevant leaders attended the meeting. The meeting commended a number of outstanding enterprises that have made outstanding contributions to the "Three-Product" strategy. Several traditional Chinese medicine products, including "Jingxin Oral Liquid" from Health Yuan Pharmaceutical Group, "Baoji Pills" from Guangzhou Wanglaoji Pharmaceutical, and "Wujibai Feng Pills" from Chen Li Ji Pharmaceutical Factory, won the title of "2018 Guangdong Provincial Pharmaceutical Industry Brand-Name Product."
According to reports, since the implementation of the "increase variety, improve quality, create brand" three-product special action, the Guangdong pharmaceutical industry has achieved remarkable results, becoming a major driver of industrial transformation and upgrading in the new era. According to data released by the Guangdong Pharmaceutical Industry Association, last year, Guangdong's pharmaceutical industry maintained rapid development. The total industrial output value of the pharmaceutical manufacturing industry in the province reached 169.542 billion yuan, and the main business income reached 162.383 billion yuan, a year-on-year increase of 16.6%. The total sales of seven major categories of pharmaceutical products in the province accounted for about 1/9 of the national total, ranking among the top provinces, municipalities, and autonomous regions.
It is worth mentioning that through the "supporting the excellent and the strong" industrial upgrading, under the effect of dual improvement in brand and quality, a number of superior products and brands have emerged in the Guangdong pharmaceutical industry. One of the outstanding representatives is "Jingxin Oral Liquid" produced by Health Yuan Pharmaceutical Group. This product is made from nine precious traditional Chinese medicines such as Paeonia lactiflora Pall, Lycium barbarum L., Schisandra chinensis (Turcz.) Baill., and Angelica sinensis (Oliv.) Diels. It can effectively alleviate various symptoms of female menopause and is safer and more effective than Western hormone therapy, with no side effects. It has been a best-seller nationwide for many years, relieving menopausal stress for millions of women and firmly holding a leading position among China's menopausal health products.
The representatives attending the meeting believed that in 2018, Guangdong's pharmaceutical industry had done a lot of work in implementing the "Three-Product" strategy and promoting the construction of a credit system, achieving remarkable results. In the future, the entire industry will continue to uphold the great banner of Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, fully implement the "Healthy China Strategy," increase varieties, improve quality, create brands, seize the opportunities for industrial development in the Guangdong-Hong Kong-Macao Greater Bay Area, continue to innovate models, and promote industry self-discipline and the construction of a credit system.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.